Responses
Regular and young investigator award abstracts
Clinical trials in progress
315 W0180 novel anti-VISTA antibody: Rationale for target patient population and first-in-human trial design in monotherapy and in combination with anti-PD1 antibody
Compose a Response to This Article
Other responses
No responses have been published for this article.
